BACKGROUND & AIMS: Mallory-Denk bodies (MDBs) are cytoplasmic protein aggregates in hepatocytes in steatohepatitis and other liver diseases. We investigated the molecular structure of keratin 8 (K8) and 18 (K18), sequestosome 1/p62, and ubiquitin, which are the major constituents of MDBs, to investigate their formation and role in disease pathogenesis. METHODS: Luminescent conjugated oligothiophenes (LCOs), h-HTAA, and p-FTAA are fluorescent amyloid ligands that specifically bind proteins with cross β-sheet conformation. We used LCOs to investigate conformational changes in MDBs in situ in human and murine livers as well as in transfection studies. RESULTS: LCO analysis showed cross β-sheet conformation in human MDBs from patients with alcoholic and nonalcoholic steatohepatitis or hepatocellular carcinoma, but not in intracellular hyaline bodies, α₁-antitrypsin deficiency, or ground-glass inclusions. LCOs bound to MDBs induced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine feeding of mice at all developmental stages. CHO-K1 cells transfected with various combinations of SQSTM1/p62, ubi, and Krt8/Krt18 showed that K8 was more likely to have cross β-sheet conformation than K18, whereas p62 never had cross β-sheet conformation. The different conformational properties of K8 and K18 were also shown by circular dichroism analysis. CONCLUSIONS: K8 can undergo conformational changes from predominantly α-helical to cross β-sheet, which would allow it to form MDBs. These findings might account for the observation that krt8⁻/⁻ mice do not form MDBs, whereas its excess facilitates MDB formation. LCOs might be used in diagnosis of liver disorders; they can be applied to formalin-fixed, paraffin-embedded tissues to characterize protein aggregates in liver cells.
BACKGROUND & AIMS: Mallory-Denk bodies (MDBs) are cytoplasmic protein aggregates in hepatocytes in steatohepatitis and other liver diseases. We investigated the molecular structure of keratin 8 (K8) and 18 (K18), sequestosome 1/p62, and ubiquitin, which are the major constituents of MDBs, to investigate their formation and role in disease pathogenesis. METHODS: Luminescent conjugated oligothiophenes (LCOs), h-HTAA, and p-FTAA are fluorescent amyloid ligands that specifically bind proteins with cross β-sheet conformation. We used LCOs to investigate conformational changes in MDBs in situ in human and murine livers as well as in transfection studies. RESULTS: LCO analysis showed cross β-sheet conformation in humanMDBs from patients with alcoholic and nonalcoholic steatohepatitis or hepatocellular carcinoma, but not in intracellular hyaline bodies, α₁-antitrypsin deficiency, or ground-glass inclusions. LCOs bound to MDBs induced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine feeding of mice at all developmental stages. CHO-K1 cells transfected with various combinations of SQSTM1/p62, ubi, and Krt8/Krt18 showed that K8 was more likely to have cross β-sheet conformation than K18, whereas p62 never had cross β-sheet conformation. The different conformational properties of K8 and K18 were also shown by circular dichroism analysis. CONCLUSIONS:K8 can undergo conformational changes from predominantly α-helical to cross β-sheet, which would allow it to form MDBs. These findings might account for the observation that krt8⁻/⁻ mice do not form MDBs, whereas its excess facilitates MDB formation. LCOs might be used in diagnosis of liver disorders; they can be applied to formalin-fixed, paraffin-embedded tissues to characterize protein aggregates in liver cells.
Authors: Raymond Kwan; Shinichiro Hanada; Masaru Harada; Pavel Strnad; Daniel H Li; M Bishr Omary Journal: FASEB J Date: 2012-02-23 Impact factor: 5.191
Authors: Therése Klingstedt; Andreas Aslund; Rozalyn A Simon; Leif B G Johansson; Jeffrey J Mason; Sofie Nyström; Per Hammarström; K Peter R Nilsson Journal: Org Biomol Chem Date: 2011-11-03 Impact factor: 3.876
Authors: Kevin A Murray; Michael P Hughes; Carolyn J Hu; Michael R Sawaya; Lukasz Salwinski; Hope Pan; Samuel W French; Paul M Seidler; David S Eisenberg Journal: Nat Struct Mol Biol Date: 2022-05-30 Impact factor: 18.361
Authors: Patrik Nordeman; Leif B G Johansson; Marcus Bäck; Sergio Estrada; Håkan Hall; Daniel Sjölander; Gunilla T Westermark; Per Westermark; Lars Nilsson; Per Hammarström; K Peter R Nilsson; Gunnar Antoni Journal: ACS Med Chem Lett Date: 2016-02-18 Impact factor: 4.345
Authors: Rozalyn A Simon; Hamid Shirani; K O Andreas Aslund; Marcus Bäck; Vahram Haroutunian; Sam Gandy; K Peter R Nilsson Journal: Chemistry Date: 2014-08-08 Impact factor: 5.236
Authors: Meghana Somlapura; Benjamin Gottschalk; Pooja Lahiri; Iris Kufferath; Daniela Pabst; Thomas Rülicke; Wolfgang F Graier; Helmut Denk; Kurt Zatloukal Journal: Int J Mol Sci Date: 2021-06-09 Impact factor: 6.208
Authors: Karin Magnusson; Hanna Appelqvist; Artur Cieślar-Pobuda; Marcus Bäck; Bertil Kågedal; Jon A Jonasson; Marek J Los; K Peter R Nilsson Journal: Front Chem Date: 2015-10-07 Impact factor: 5.221
Authors: Therése Klingstedt; Cristiane Blechschmidt; Anna Nogalska; Stefan Prokop; Bo Häggqvist; Olof Danielsson; W King Engel; Valerie Askanas; Frank L Heppner; K Peter R Nilsson Journal: Chembiochem Date: 2013-02-28 Impact factor: 3.164
Authors: Therése Klingstedt; Hamid Shirani; K O Andreas Åslund; Nigel J Cairns; Christina J Sigurdson; Michel Goedert; K Peter R Nilsson Journal: Chemistry Date: 2013-06-18 Impact factor: 5.236